Lee, A.G.; Lee, S.-H.; Jang, M.; Lee, S.J.; Shin, H.J.
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins 2021, 13, 77.
https://doi.org/10.3390/toxins13020077
AMA Style
Lee AG, Lee S-H, Jang M, Lee SJ, Shin HJ.
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins. 2021; 13(2):77.
https://doi.org/10.3390/toxins13020077
Chicago/Turabian Style
Lee, Andrew G., Shin-Hyo Lee, Minsu Jang, Sang Jae Lee, and Hyun Jin Shin.
2021. "Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial" Toxins 13, no. 2: 77.
https://doi.org/10.3390/toxins13020077
APA Style
Lee, A. G., Lee, S.-H., Jang, M., Lee, S. J., & Shin, H. J.
(2021). Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins, 13(2), 77.
https://doi.org/10.3390/toxins13020077